Dyne Therapeutics Inc (NASDAQ:DYN) price on Thursday, April 10, fall -7.55% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.98.
A look at the stock’s price movement, the close in the last trading session was $7.55, moving within a range at $6.71 and $7.42. The beta value (5-Year monthly) was 1.209. Turning to its 52-week performance, $47.45 and $6.36 were the 52-week high and 52-week low respectively. Overall, DYN moved -43.53% over the past month.
Dyne Therapeutics Inc’s market cap currently stands at around $789.59 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DYN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 7 recommend DYN as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
DYN’s current price about -32.92% and -43.25% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 27.01, while 7-day volatility ratio is 16.97% and 9.68% in the 30-day chart. Further, Dyne Therapeutics Inc (DYN) has a beta value of 1.29, and an average true range (ATR) of 1.00. Analysts have given the company’s stock an average 52-week price target of $47, forecast between a low of $46 and high of $48. Looking at the price targets, the low is -559.03% off current price level while to achieve the yearly target high, price needs to move -587.68%. Nonetheless, investors will most likely welcome a -573.35% jump to $47 which is the analysts’ median price.
If we refocus on Dyne Therapeutics Inc (NASDAQ:DYN), historical trading data shows that trading volumes averaged 3.37 over the past 10 days and 2.42 million over the past 3 months. The company’s latest data on shares outstanding shows there are 102.32 million shares.
The 22.80% of Dyne Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 80.95% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12.38 million on 2025-03-14, giving us a short ratio of 7.74. The data shows that as of 2025-03-14 short interest in Dyne Therapeutics Inc (DYN) stood at 1276.0 of shares outstanding, with shares short rising to 10.9 million registered in 2025-02-14. Current price change has pushed the stock -70.37% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DYN stock continues to rise going into the next quarter.
